Presents information on how the administration of interleukin 12 with pulse interleukin 2 can reduce the further development of metastatic murine renal carcinoma. Information on interleukin 12 and 2; Research methodology; Treatment regimens for mice under research; Analysis of data; Results of study; Discussion of results; Literature references.